Australia's most trusted
source of pharma news
Saturday, 20 April 2024
Posted 12 August 2022 PM
Moderna boss Stephane Bancel has likened the company's Covid vaccine, Spikevax, to Apple's mega product, the iPhone, insisting it will improve with new add-ons over time.
As red-hot demand for Covid vaccines subsides, the company is building the foundations to continue to grow with a combination Covid, flu and respiratory syncytial virus (RSV) shot expected in three to five years.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.